Hysterectomy and oophorectomy are unrelated to bone loss in older women
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study investigated the relationship between hysterectomy, oophorectomy, and bone loss in older women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveThe relation of hysterectomy and oophorectomy to change in bone mineral density (BMD) was examined in older women using and not using estrogen replacement therapy (ERT).MethodsWomen aged 60-80 years from the Rancho Bernardo Study attended clinic visits in 1988-1991 and 1992-1995 when hysterectomy and oophorectomy were ascertained, ERT use was validated and spine and hip BMD was assessed at both visits with DEXA. Women were either current ERT users or nonusers at both visits.ResultsAmong these 447 women, average age was 71 (S.D.=9.0); average years postmenopause was 24.7 (S.D.=10.9). Overall, 122 had a hysterectomy with ovarian conservation and 91 had a hysterectomy with bilateral oophorectomy; 41% reported current ERT use for an average duration of 19.1 years (S.D.=10.8). Hysterectomized women were 2.3 times more likely to report ERT use than intact women (P<0.001). Comparisons adjusted for age, obesity, and age at menopause but not for ERT use showed hysterectomized women had less bone loss per year at the hip than intact women (P<0.05). However, this difference was explained by ERT; after adjustment for ERT, mean hip bone loss per year was -0.57% for intact women, -0.42% for hysterectomized women with ovarian conservation and -0.32% for bilaterally oophorectomized women (P's>0.10). There were no differences by hysterectomy or oophorectomy in bone loss at the spine or femoral neck. For all sites, women using ERT had higher BMD at both visits than nonusers (P's<0.001). Stratification by ERT showed that within users and nonusers, there were no differences in BMD or bone loss at any site by hysterectomy or oophorectomy.ConclusionsThere are no long term effects of hysterectomy and bilateral oophorectomy on bone loss. Women who use ERT have better BMD than nonusers.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age 1993
- Ovarian failure phenomena after hysterectomy. 1986
Cited by (1)
References (50)
- Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age via openalex
- Ovarian failure phenomena after hysterectomy. via openalex
- doi:10.1093/oxfordjournals.aje.a113388 via openalex
- doi:10.2105/ajph.78.7.852 via openalex
- doi:10.1093/oxfordjournals.aje.a116954 via openalex
- doi:10.1136/bmj.3.5879.515 via openalex
- doi:10.1016/s0009-9260(68)80107-2 via openalex
- doi:10.1093/oxfordjournals.aje.a009352 via openalex
- doi:10.1016/s0895-4356(01)00362-6 via openalex
- doi:10.1056/nejm198411153112002 via openalex
- doi:10.2106/00004623-197456060-00016 via openalex
- doi:10.1016/0531-5565(94)90008-6 via openalex
- W41988930 via openalex
- W143579009 via openalex
- W185532356 via openalex
- W1683226090 via openalex
- doi:10.1001/jama.196.3.219 via openalex
- doi:10.1016/s0169-6009(08)80039-6 via openalex
- doi:10.1093/oxfordjournals.aje.a115572 via openalex
- doi:10.7326/0003-4819-97-5-699 via openalex
- doi:10.1016/s0749-3797(18)30303-9 via openalex
- doi:10.1016/0378-5122(93)90122-x via openalex
- doi:10.1016/0378-5122(93)90057-o via openalex
- doi:10.1001/archinte.160.20.3065 via openalex
- doi:10.2105/ajph.84.10.1653 via openalex
- doi:10.2105/ajph.87.4.676 via openalex
- doi:10.1016/0378-5122(93)90004-2 via openalex
- doi:10.1016/0378-5122(82)90065-2 via openalex
- doi:10.1016/0020-7292(90)91020-q via openalex
- W2396446562 via openalex
- W2433422182 via openalex
- W4285719527 via openalex
- W6601750530 via openalex
- W6605793041 via openalex
- W6637405764 via openalex
- W6712676338 via openalex
- W6717774521 via openalex
- doi:10.1111/j.1479-828x.1998.tb03111.x via openalex
- doi:10.1097/00042192-199906040-00006 via openalex
- doi:10.1001/jama.1966.03100160069020 via openalex
- doi:10.1016/0378-5122(95)00940-m via openalex
- doi:10.1016/0029-7844(94)00456-n via openalex
- doi:10.1016/s0015-0282(16)49942-5 via openalex
- doi:10.1001/jama.277.7.543 via openalex
- doi:10.1016/0378-5122(94)00878-b via openalex
- doi:10.1001/archinte.162.6.665 via openalex
- doi:10.1007/bf02555081 via openalex
- doi:10.1016/s0029-7844(01)01723-9 via openalex
- doi:10.1016/s0301-2115(98)00313-3 via openalex
- doi:10.1046/j.1365-2362.1999.00541.x via openalex
Cited by (1)
SciLite annotations
chemicals 2
mineral
estrogen
Source provenance
- openalex
- last seen: 2026-05-11T06:18:49.075943+00:00
- scilite
- last seen: 2026-05-18T04:57:49.680383+00:00
- unpaywall
- last seen: 2026-08-02T06:40:33.490260+00:00
License: CC0
· commercial use OK